You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

[11C]hydroxyephedrine (HED)

Showing 76 - 100 of 442
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuropsychiatric Syndromes Trial in Houston (PET with radiotracer [11C]PBR-28 ( or [11C]ER176), Affective challenge)

Recruiting
  • Neuropsychiatric Syndromes
  • PET with radiotracer [11C]PBR-28 ( or [11C]ER176)
  • Affective challenge
  • Houston, Texas
    BBSB at UTHealth
Sep 27, 2021

Prostate Cancer Patients Trial in Philadelphia (11C-Acetate)

Completed
  • Prostate Cancer Patients
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
May 12, 2022

11C-PIB PET Study in MESA at Columbia University

Enrolling by invitation
  • Cognitive Impairment
  • +3 more
  • New York, New York
    Columbia University Irving Medical Center
Feb 2, 2022

Parkinson Disease Trial in Ann Arbor (Clarithromycin (Not used as of 4/2020), Placebo (Not used as of 4/2020), Transdermal

Completed
  • Parkinson Disease
  • Clarithromycin (Not used as of 4/2020)
  • +3 more
  • Ann Arbor, Michigan
    University of Michigan Health System Functional Neuroimaging, Co
Mar 22, 2022

Acute Decompensated Heart Failure Trial in Birmingham (Cardiac Perfusion and Metabolism with [11C] Acetate PET/CT)

Withdrawn
  • Acute Decompensated Heart Failure
  • Cardiac Perfusion and Metabolism with [11C] Acetate PET/CT
  • Birmingham, Alabama
    University of Alabama at Birmingham Medical Center
Feb 15, 2022

Bipolar Disorder Trial in New York (Ethyl Eicosapentaenoic Acid)

Withdrawn
  • Bipolar Disorder
  • Ethyl Eicosapentaenoic Acid
  • New York, New York
    New York State Psychiatric Institute/Columbia University Medical
Oct 12, 2022

Huntington Disease Trial in Leuven (11C-UCB-J PET-CT, 18F-FDG PET-MR)

Active, not recruiting
  • Huntington Disease
  • 11C-UCB-J PET-CT
  • 18F-FDG PET-MR
  • Leuven, Vlaams-Brabant, Belgium
    UZ Leuven
May 18, 2022

Parkinson Disease Trial in Leuven (11C-UCB-J PET-CT, 18F-PE2I PET-MR)

Completed
  • Parkinson Disease
  • 11C-UCB-J PET-CT
  • 18F-PE2I PET-MR
  • Leuven, Vlaams-Brabant, Belgium
    UZ Leuven
May 18, 2022

Aberrant Synaptic Plasticity in Cocaine Use Disorder: A

Recruiting
  • Cocaine Use Disorder
  • Healthy Controls
  • 11C-UCB-J
  • New Haven, Connecticut
    Connecticut Mental Health Center
Aug 10, 2022

Heart Failure Trial in Turku (sacubitril/valsatran, valsartan, to valsartan)

Recruiting
  • Heart Failure
  • Turku, Finland
    Novartis Investigative Site
Dec 2, 2021

Dysphagia Trial in Canada, United States (RE-ACTIVE, PRO-ACTIVE EAT, PRO-ACTIVE EAT + EXERCISE)

Recruiting
  • Dysphagia
  • RE-ACTIVE
  • +2 more
  • Miami, Florida
  • +12 more
Nov 24, 2022

Head Neck Cancer Trial (Endovascular embolization)

Not yet recruiting
  • Head and Neck Cancer
  • Endovascular embolization
  • (no location specified)
Jul 26, 2022

Healthy Participants Trial in London ([11C]-Lu AF88370)

Completed
  • Healthy Participants
  • [11C]-Lu AF88370
  • London, United Kingdom
    Invicro
Jul 12, 2022

Biodistribution of [11C]PIB in Risk Factors for Alzheimer's

Enrolling by invitation
  • Alzheimer Disease
  • Mild Cognitive Impairment
    • Winston-Salem, North Carolina
      Wake Forest Baptist Medical Center
    Apr 29, 2022

    Chronic Pain Trial in New York ([11C]-NOP46, PET/CT scan)

    Recruiting
    • Chronic Pain
    • New York, New York
      Columbia University Irving Medical Center
    Jul 2, 2021

    Amino Acid PET/MRI in Evaluation of Glioma and Brain Metastases

    Recruiting
    • Brain Neoplasms
    • Diagnostic Amino acid PET/MRI examination
    • Bergen, Norway
    • +2 more
    Nov 1, 2021

    Brown Adipose Tissue Activity in Response to Semaglutide

    Not yet recruiting
    • Obesity
    • Semaglutide Injectable Product
    • (no location specified)
    Jan 17, 2023

    Mitral Valve Regurgitation Trial in Birmingham ([11C] acetate)

    Recruiting
    • Mitral Valve Regurgitation
    • [11C] acetate
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jun 9, 2022

    Ovarian Cancer Trial in Birmingham ([11C]PiB and 18F-labeled DPA-714 PET scan)

    Not yet recruiting
    • Ovarian Cancer
    • [11C]PiB and 18F-labeled DPA-714 PET scan
    • Birmingham, Alabama
      The University of Alabama at Birmingham
    Jun 9, 2022

    To Determine Brain Target Occupancy of BPN14770 Trial in New York (BPN14770, T2310)

    Withdrawn
    • To Determine Brain Target Occupancy of BPN14770
    • BPN14770, T2310
    • New York, New York
      Weill Cornell Medicine
    Dec 16, 2021

    Traumatic Brain Injury (TBI), Healthy Trial run by the NIMH ([11C]PBR28 and Positron Emission Tomography (PET))

    Completed
    Has Results
    • Traumatic Brain Injury (TBI)
    • Healthy
    • [11C]PBR28 and Positron Emission Tomography (PET)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jul 12, 2021

    Prostate Cancer Metastatic Trial in Leiden (Enzalutamide, 11C or 18F-Choline PET/CT, Whole body MRI)

    Completed
    • Prostate Cancer Metastatic
    • Leiden, Netherlands
      Leiden University Medical Center
    Apr 6, 2022

    Imaging Biomarkers in Preclinical and Symptomatic AD

    Recruiting
    • Alzheimer Disease
    • [11C] Pittsburgh Compound-B (PIB)
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jun 29, 2021

    Healthy Volunteers Trial in Uppsala (myBluTM Formulation 1, myBluTM Formulation 2)

    Active, not recruiting
    • Healthy Volunteers
    • myBluTM Formulation 1
    • myBluTM Formulation 2
    • Uppsala, Sweden
      PET Centre, Uppsala University Hospital
    May 12, 2021

    Obesity, Childhood Obesity Trial in Knoxville (FBT, FBT+Variety)

    Recruiting
    • Obesity
    • Childhood Obesity
    • FBT
    • FBT+Variety
    • Knoxville, Tennessee
      Healthy Eating and Activity Lab, University of Tennessee
    Oct 30, 2022